rss
Heart 2006;92:1821-1826 doi:10.1136/hrt.2006.089060
  • Interventional cardiology and surgery

Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. Is there protection by remote ischaemic preconditioning?

  1. E K Iliodromitis1,
  2. S Kyrzopoulos2,
  3. I A Paraskevaidis1,
  4. K G Kolocassides1,
  5. S Adamopoulos2,
  6. G Karavolias2,
  7. D T Kremastinos1
  1. 12nd University Department of Cardiology, Medical School, Attikon General Hospital, University of Athens, Athens, Greece
  2. 22nd Department of Cardiology, Onassis Cardiac Center, Athens, Greece
  1. Correspondence to:
    E K Iliodromitis
    2nd University Department of Cardiology, Medical School, Attikon General Hospital, University of Athens, Athens, Greece; iliodromitis{at}yahoo.gr
  • Accepted 3 July 2006
  • Published Online First 19 July 2006

Abstract

Aim: To investigate whether remote ischaemic preconditioning (RIPC) can attenuate the inflammatory response and enzyme leakage that can occur after uncomplicated routine percutaneous coronary intervention (PCI).

Methods: 41 consecutive normotensive patients with stable angina and single-vessel disease were assigned to be exposed to RIPC (n = 20) or not (control group; n = 21) before elective PCI with stent implantation. RIPC was induced by three cycles of 5-min ischaemia–reperfusion of both upper limbs (inflation/deflation of blood pressure cuff). C reactive protein (CRP), creatine phosphokinase (CK), CK cardiac isoenzyme (CK-MB) and troponin I (TNI) were serially measured for 48 h.

Results: No difference in baseline values was observed between the groups. The CRP rose significantly (p<0.001) and at 48 h was similarly increased (>fourfold) in both groups (15.7 (2.6) v 14.0 (3.3) mg/l, RIPC v control; p = NS). However, sub-group analysis on the basis of statin use showed that the highest rise was in the group of patients with RIPC not taking statins and was significantly greater than in patients with RIPC taking statins (23.8 (3.71) v 11.4 (3.0) mg/l, respectively, p<0.01). Both CK-MB and TNI leakage were raised (slightly but significantly) after PCI in controls at 24 h compared with baseline values. However, this small rise was significantly worse after RIPC (CK-MB, 1.33 (0.27) v 3.57 (0.97) ng/ml, p<0.01; TNI, 0.255 (0.059) v 0.804 (0.232) ng/ml, p<0.05, respectively at 24 h). The increase was more marked in the RIPC subgroup not taking statins.

Conclusions: RIPC does not reduce, but exacerbates, the enzyme and TNI release from the heart after single-vessel angioplasty with stent. Furthermore, the increased circulating CRP remains raised. It seems that there is an enhanced inflammatory response after RIPC in the absence of statin treatment.

Footnotes

  • Published Online First 19 July 2006

  • Competing interests: None declared.

Responses to this article

This Article

  1. All Versions of this Article:
    1. hrt.2006.089060v1
    2. 92/12/1821 most recent

Services

  1. Request permissions

Social bookmarking

Latest from Education in Heart

Latest from Education in Heart

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Heart.
View free sample issue >>

Free archive
The full back archive is now available for Heart. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.